Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.

[1]  G. Romano,et al.  Contrast agents and renal cell apoptosis. , 2008, European heart journal.

[2]  P. McCullough,et al.  Contrast-induced acute kidney injury. , 2018, Journal of the American College of Cardiology.

[3]  S. Ito,et al.  Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease , 2007, Clinical and Experimental Nephrology.

[4]  M. Fine,et al.  Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. , 2006, Journal of the American Society of Nephrology : JASN.

[5]  P. Aspelin,et al.  Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach , 2006, Circulation.

[6]  G. Deray,et al.  How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. , 2006, Kidney international. Supplement.

[7]  F. Artunc,et al.  Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. , 2005, International journal of cardiology.

[8]  T. Hedner,et al.  Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery , 1994, Intensive Care Medicine.

[9]  H. Predel,et al.  Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure , 1991, Klinische Wochenschrift.

[10]  T. Fehr,et al.  Contrast nephropathy: review focusing on prevention. , 2004, Journal of the American College of Cardiology.

[11]  S. Ricksten,et al.  Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial* , 2004, Critical care medicine.

[12]  L. Bachmann,et al.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. , 2004, Journal of the American Society of Nephrology : JASN.

[13]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[14]  K. Berg,et al.  Nephrotoxic Effects of X‐Ray Contrast Media , 2004, Journal of toxicology. Clinical toxicology.

[15]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.

[16]  E. Bates,et al.  Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[18]  C. Viscoli,et al.  The Effect of Acute Renal Failure on Mortality , 1997 .

[19]  R. Katzberg,et al.  Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. , 1997, Radiology.

[20]  R. Lafayette,et al.  Anaritide in Acute Tubular Necrosis , 1997 .

[21]  C. Viscoli,et al.  The effect of acute renal failure on mortality. A cohort analysis. , 1996, JAMA.

[22]  C. Price,et al.  Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. , 1995, Kidney international.

[23]  M. F. Schultz,et al.  Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. , 1994, Kidney international.

[24]  T. Hedner,et al.  Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. , 1994, Journal of cardiothoracic and vascular anesthesia.

[25]  R. Schrier,et al.  Effects of atrial natriuretic peptide in clinical acute renal failure. , 1994, Kidney international.

[26]  P. Kurnik,et al.  Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. , 1994, Kidney international.

[27]  A. Lerman,et al.  Endothelin in a model of acute ischemic renal dysfunction: modulating action of atrial natriuretic factor. , 1992, Journal of the American Society of Nephrology : JASN.

[28]  S. Falk,et al.  Effects of atriopeptin III on isolated rat afferent and efferent arterioles. , 1991, The American journal of physiology.

[29]  H. Predel,et al.  Atrial natriuretic peptide in patients with diabetes mellitus type I. Effects on systemic and renal hemodynamics and renal excretory function. , 1990, American journal of hypertension.

[30]  P. Kurnik,et al.  Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. , 1990, The Journal of laboratory and clinical medicine.

[31]  R. Schrier,et al.  Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. , 1989, Kidney international.

[32]  K. Goetz.  Physiology and pathophysiology of atrial peptides. , 1988, The American journal of physiology.

[33]  C. Davis,et al.  Effect of atrial natriuretic peptides on renal medullary solute gradients. , 1987, The American journal of physiology.

[34]  R. Schrier,et al.  In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. , 1987, The Journal of clinical investigation.

[35]  D. Roy.  Effect of synthetic ANP on renal and loop of Henle functions in the young rat. , 1986, The American journal of physiology.